Onuma Y - Search Results

1

External Validation of the FREEDOM Score for Individualized Decision Making Between CABG and PCI.

Takahashi K, Serruys PW, Fuster V, Farkouh ME, Spertus JA, Cohen DJ, Park SJ, Park DW, Ahn JM, Onuma Y, Kent DM, Steyerberg EW, van Klaveren D; SYNTAX, BEST, and FREEDOM Trial investigators. Takahashi K, et al. Among authors: onuma y. J Am Coll Cardiol. 2022 Apr 19;79(15):1458-1473. doi: 10.1016/j.jacc.2022.01.049. J Am Coll Cardiol. 2022. PMID: 35422242 Free article.

2

Revascularization in the high-risk patient: multivessel disease.

Onuma Y, Daemen J, Kukreja N, Serruys P. Onuma Y, et al. Minerva Cardioangiol. 2007 Oct;55(5):579-92. Minerva Cardioangiol. 2007. PMID: 17912164 Review.

3

The future of drug-eluting stents.

Kukreja N, Onuma Y, Daemen J, Serruys PW. Kukreja N, et al. Among authors: onuma y. Pharmacol Res. 2008 Mar;57(3):171-80. doi: 10.1016/j.phrs.2008.01.012. Epub 2008 Feb 2. Pharmacol Res. 2008. PMID: 18339557 Review.

4

A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial.

Ormiston JA, Serruys PW, Regar E, Dudek D, Thuesen L, Webster MW, Onuma Y, Garcia-Garcia HM, McGreevy R, Veldhof S. Ormiston JA, et al. Among authors: onuma y. Lancet. 2008 Mar 15;371(9616):899-907. doi: 10.1016/S0140-6736(08)60415-8. Lancet. 2008. PMID: 18342684 Clinical Trial.

5

Four-year clinical follow-up of the rapamycin-eluting stent evaluated at Rotterdam Cardiology Hospital registry.

Daemen J, Kukreja N, van Twisk PH, Onuma Y, de Jaegere PP, van Domburg R, Serruys PW. Daemen J, et al. Among authors: onuma y. Am J Cardiol. 2008 Apr 15;101(8):1105-11. doi: 10.1016/j.amjcard.2007.11.074. Epub 2008 Feb 20. Am J Cardiol. 2008. PMID: 18394442

6

Coronary plaque composition as assessed by greyscale intravascular ultrasound and radiofrequency spectral data analysis.

Gonzalo N, García-García HM, Ligthart J, Rodriguez-Granillo G, Meliga E, Onuma Y, Schuurbiers JC, Bruining N, Serruys PW. Gonzalo N, et al. Among authors: onuma y. Int J Cardiovasc Imaging. 2008 Dec;24(8):811-8. doi: 10.1007/s10554-008-9324-2. Epub 2008 Jun 12. Int J Cardiovasc Imaging. 2008. PMID: 18548332

7

Three-year survival following multivessel percutaneous coronary intervention with bare-metal or drug-eluting stents in unselected patients.

Kukreja N, Onuma Y, Garcia-Garcia HM, Daemen J, van Domburg R, Serruys PW; Interventional Cardiologists of the Thoraxcenter (2000-5). Kukreja N, et al. Among authors: onuma y. Am J Cardiol. 2009 Jan 15;103(2):203-11. doi: 10.1016/j.amjcard.2008.08.068. Epub 2008 Nov 19. Am J Cardiol. 2009. PMID: 19121437

8

Advances in stent drug delivery: the future is in bioabsorbable stents.

Wykrzykowska JJ, Onuma Y, Serruys PW. Wykrzykowska JJ, et al. Among authors: onuma y. Expert Opin Drug Deliv. 2009 Feb;6(2):113-26. doi: 10.1517/17425240802668495. Expert Opin Drug Deliv. 2009. PMID: 19239384 Review.

9

A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods.

Serruys PW, Ormiston JA, Onuma Y, Regar E, Gonzalo N, Garcia-Garcia HM, Nieman K, Bruining N, Dorange C, Miquel-Hébert K, Veldhof S, Webster M, Thuesen L, Dudek D. Serruys PW, et al. Among authors: onuma y. Lancet. 2009 Mar 14;373(9667):897-910. doi: 10.1016/S0140-6736(09)60325-1. Lancet. 2009. PMID: 19286089

10

Interventional treatment in diabetics in the era of drug-eluting stents and compliance to the ESC guidelines: lessons learned from the Euro Heart Survey Programme.

Onuma Y, Kukreja N, Ramcharitar S, Hochadel M, Gitt A, Serruys P. Onuma Y, et al. EuroIntervention. 2009 Mar;4(5):578-87. doi: 10.4244/eijv4i5a98. EuroIntervention. 2009. PMID: 19378677

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

821 results

Search Page